Replies to post #42556 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

On this we disagree. Attention isn't being diverted from Kevetrin. The Kevetrin phase I trial is on auto pilot and other studies are already lined up that the company won't be paying for.






In Reply to 'noretreat'
I agree with you. Nice summary of where we are right now. I predict there will be issues with the Polymedix assets...issues that will continue to divert MGMT from Kevetrin, the big prize.

[TheProgressive]

I'd have to disagree also. Can you explain to me how or what exactly is being "diverted" from Kevetrin? When taking into account the current trial at Dana Farber, the trial on queue at University of Bologna once MTD is reached at DF, and the studies in progress that will lead into trials at BIDMC and MDA, I am curious as to what more you think should be happening to "divert" enough attention back to Kevetrin.

Genuinely curious, would like to hear your take. Do you feel they should pursue even more trials? early partnerships? do you think they can somehow take more control or influence at DF? Not sure I understand your perspective. Thanks NR!

[edge]

Yep, another boogeyman enters the mix and sounds like you better sell out post haste...........getting uglier by the day.